SynBioBeta Speaker
Paul Schnier
AVP, Oncology
Lilly
May 2026, SynBioBeta
Speaker
Paul Schnier is Associate Vice President of Multi-Omics in the Oncology Therapeutic Area at Lilly, where he leads the integration of advanced analytical and multi-omics platforms across discovery and development. His team enables data-driven decisions from target biology through clinical translation, with a focus on elucidating complex and low-abundance proteins, including the “dark immunopeptidome,” to inform mechanism of action and therapeutic strategy. Paul has extensive experience building multidisciplinary teams and applying innovative technologies to accelerate the development of next-generation medicines. He holds a Ph.D. in Physical Chemistry from UC Berkeley and has held scientific leadership roles at Amgen, Genentech, and UCSF.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.